21,000 lymphoma patients join landmark study to uncover what really affects survival

NCT ID NCT04996706

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study follows 21,000 adults newly diagnosed with non-Hodgkin lymphoma to learn which factors—like genetics, lifestyle, and treatment—affect survival and quality of life. Researchers will track health outcomes over time without providing a new treatment. The goal is to improve predictions and find better ways to care for lymphoma patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hodgkins lymphoma immune system disorder immunoproliferative disorder lymphatic system disorder lymphoma, non-Hodgkin, familial lymphoproliferative syndrome neoplasm Neoplasms by Histologic Type non-Hodgkin lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYMPHOMA, NON-HODGKIN

Contacts and locations

Locations

Emory St. Joseph's Hospital

Atlanta, Georgia, 30342, United States
Emory University Hospital Midtown

Atlanta, Georgia, 30308, United States
MD Anderson Cancer Center

Houston, Texas, 77030, United States
Mayo Clinic

Rochester, Minnesota, 55902, United States
Mayo Clinic in Arizona

Scottsdale, Arizona, 85259, United States
Mayo Clinic in Florida

Jacksonville, Florida, 32224-9980, United States
University of Iowa

Iowa City, Iowa, 52242, United States
University of Miami: Sylvester Comprehensive Cancer Center

Miami, Florida, 33136, United States
University of Rochester Medical Center

Rochester, New York, 14642, United States
Washington University School of Medicine in St. Louis

St Louis, Missouri, 63110, United States
Weill Cornell Medical College

New York, New York, 10065, United States
Winship Cancer Institute of Emory University

Atlanta, Georgia, 30322, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.